$FBIO News Article - Cyprium Therapeutics, a Fortr
Post# of 35792
(Total Views: 64)
Posted On: 12/06/2023 8:50:49 AM
$FBIO News Article - Cyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd. https://marketwirenews.com/news-releases/cypr...05534.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼